-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on AVITA Medical, Raises Price Target to $11

Benzinga·08/19/2026 12:29:37
語音播報
BTIG analyst Ryan Zimmerman maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the price target from $7 to $11.